Phoenix Group reports numbers moving in right direction ahead of Standard Life rebrand

Phoenix Group reported robust H1 2025 results, with operating cash generation up 9% to £705 million, adjusted operating profit climbing 25% to £451 million, and IFRS losses after tax narrowing significantly to £156 million. The insurer also improved its Solvency II coverage to 175% and raised its interim dividend by 2.6%, all ahead of its planned rebrand to Standard Life PLC in March 2026, aiming to leverage the established brand and reaffirm 2026 financial targets.

Analysis

Phoenix Group Holdings reported a robust first half for 2025, demonstrating positive momentum across key financial and operational metrics ahead of its planned strategic rebrand. Operating cash generation grew by a solid 9% to £705 million, while adjusted operating profit saw a significant 25% increase to £451 million, indicating strong underlying business performance. This growth was broad-based, with Pensions & Savings profit rising 20% and Retirement Solutions profit increasing 36% on the back of strong annuity and bulk purchase activity. Balance sheet health has notably improved, with the Solvency II coverage ratio strengthening to 175% and leverage declining to 34%. Furthermore, the company made substantial progress toward statutory profitability, narrowing its IFRS after-tax loss to £156 million from £646 million in the prior-year period. Management's confidence is reflected in a 2.6% increase in the interim dividend and the reaffirmation of its 2026 financial targets, providing a stable outlook as it prepares to transition its corporate identity to Standard Life PLC in March 2026.

Key Decisions for Investors

• Investors should weigh the strong operational momentum, evidenced by the 25% rise in adjusted operating profit and improved solvency, against the persistent IFRS net loss when evaluating the current valuation.
• The upcoming rebrand to Standard Life PLC in March 2026 presents a potential catalyst for growth, and progress toward the reaffirmed 2026 financial targets should be monitored as a key performance indicator.
• For income-oriented portfolios, the 2.6% increase in the interim dividend signals management's confidence and a continued commitment to shareholder returns, reinforcing the stock's potential appeal for its yield.